Trial
NCT03796195
(SGB) in Men Treated for Prostate Cancer Improve Hot Flashes
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Northwestern University
Collaborators
—
Condition
Prostate Cancer
Intervention
.5% Bupivacaine
Why stopped
Enrollment issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-25